Chai Christopher Y
Chief Financial Officer at Principia Biopharma Inc.; Chief Financial Officer at MAP Pharmaceuticals, Inc.
- Sold, on record
- $3.3M
- Dollars the filings state
- Form 4 sales
- 11
- Latest Aug 18, 2020
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- Principia Biopharma Inc.Chief Financial Officer
- MAP Pharmaceuticals, Inc.Chief Financial Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- MAP Pharmaceuticals, Inc.116,021 shares
- Principia Biopharma Inc.22,500 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale MAP Pharmaceuticals, Inc.UnusualMar 24, 2010 2010
Sold 16,000 shares at $16.60 ($266k)
Chai Christopher Y, Chief Financial Officer
Sold 70.5% of holdings ($377k position)6,709 shares left1.6x usual sizeFiling
- 2 Form 4 sale MAP Pharmaceuticals, Inc.UnusualMay 20, 2010 +57 days
Sold 16,000 shares at $14.77 ($236k)
Chai Christopher Y, Chief Financial Officer
Sold 70.5% of holdings ($335k position)6,709 shares left1.6x usual sizeFiling
- 3 Form 4 sale MAP Pharmaceuticals, Inc.UnusualJul 21, 2010 +62 days
Sold 16,000 shares at $12.71 ($203k)
Chai Christopher Y, Chief Financial Officer
Sold 70.5% of holdings ($289k position)6,709 shares left1.6x usual sizeFiling
- 4 Form 4 sale MAP Pharmaceuticals, Inc.UnusualSep 20, 2010 +61 days
Sold 16,000 shares at $14.05 ($225k)
Chai Christopher Y, Chief Financial Officer
Sold 70.5% of holdings ($319k position)6,709 shares left1.2x usual sizeFiling
- 5 Form 4 sale MAP Pharmaceuticals, Inc.UnusualSep 20, 2011 +365 days
Sold 32,000 shares at $15.38 ($492k)
Chai Christopher Y, Chief Financial Officer
Sold 80.6% of holdings ($611k position)7,703 shares left2x usual sizeFiling
- 6 Form 4 sale Principia Biopharma Inc.UnusualFeb 18, 2020 +3073 days
Sold 7,500 shares at $65.89 ($494k)
Chai Christopher Y, Chief Financial Officer
Sold 61.1% of holdings ($808k position)4,766 shares leftFirst sale on recordFiling
- 7 Form 4 sale Principia Biopharma Inc.UnusualMay 19, 2020 +91 days
Sold 7,500 shares at $65.10 ($488k)
Chai Christopher Y, Chief Financial Officer
Sold 67.9% of holdings ($719k position)3,539 shares leftFiling
- 8 Form 4 sale Principia Biopharma Inc.UnusualAug 18, 2020 +91 days
Sold 7,500 shares at $99.37 ($745k)
Chai Christopher Y, Chief Financial Officer
Sold 67.9% of holdings ($1.1M position)3,539 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (11)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2020 | Aug 20, 2020 | Principia Biopharma Inc. | Chief Financial Officer | Form 4 sale | 7,500 | $745k | 67.9% | Unusual | SEC |
| May 19, 2020 | May 21, 2020 | Principia Biopharma Inc. | Chief Financial Officer | Form 4 sale | 7,500 | $488k | 67.9% | Unusual | SEC |
| Feb 18, 2020 | Feb 20, 2020 | Principia Biopharma Inc. | Chief Financial Officer | Form 4 sale | 7,500 | $494k | 61.1% | Unusual | SEC |
| Sep 20, 2011 | Sep 22, 2011 | MAP Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 32,000 | $492k | 80.6% | Unusual | SEC |
| Sep 20, 2010 | Sep 22, 2010 | MAP Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 16,000 | $225k | 70.5% | Unusual | SEC |
| Jul 21, 2010 | Jul 22, 2010 | MAP Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 16,000 | $203k | 70.5% | Unusual | SEC |
| May 20, 2010 | May 21, 2010 | MAP Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 16,000 | $236k | 70.5% | Unusual | SEC |
| Mar 24, 2010 | Mar 25, 2010 | MAP Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 16,000 | $266k | 70.5% | Unusual | SEC |
| Nov 2, 2009 | Nov 4, 2009 | MAP Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 10,000 | $81k | 66.8% | Unusual | SEC |
| Oct 1, 2009 | Oct 5, 2009 | MAP Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 10,000 | $103k | 66.8% | Unusual | SEC |
| Feb 9, 2009 | Feb 11, 2009 | MAP Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 21 | $273 | 100.0% | Unusual | SEC |